These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6719039)

  • 1. Effect of ursodeoxycholic acid treatment on intestinal absorption of triglycerides in man.
    Einarsson K; Björkhem I; Eklöf R; Ewerth S; Nilsell K; Blomstrand R
    Scand J Gastroenterol; 1984 Mar; 19(2):283-8. PubMed ID: 6719039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration.
    Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F
    Gastroenterology; 1980 Feb; 78(2):214-9. PubMed ID: 7350042
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects.
    Sauter GH; Thiessen K; Parhofer KG; Jüngst C; Fischer S; Jüngst D
    Digestion; 2004; 70(2):79-83. PubMed ID: 15375335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of three different dihydroxy bile acids on intestinal cholesterol absorption in normal volunteers.
    Leiss O; von Bergmann K; Streicher U; Strotkoetter H
    Gastroenterology; 1984 Jul; 87(1):144-9. PubMed ID: 6724257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
    Miettinen TE; Tarpila S; Gylling H
    Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
    Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis.
    Lukivskaya O; Zavodnik L; Knas M; Buko V
    Adv Med Sci; 2006; 51():54-9. PubMed ID: 17357278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic and deoxycholic acids: A good and a bad bile acid for intestinal calcium absorption.
    Rodríguez V; Rivoira M; Marchionatti A; Pérez A; Tolosa de Talamoni N
    Arch Biochem Biophys; 2013 Dec; 540(1-2):19-25. PubMed ID: 24096173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ursodeoxycholate and its taurine conjugate on bile acid synthesis and cholesterol absorption.
    Hardison WG; Grundy SM
    Gastroenterology; 1984 Jul; 87(1):130-5. PubMed ID: 6724255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
    Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the triolein breath test for the demonstration of fat malabsorption in coeliac disease.
    Akesson B; Florén CH
    Scand J Gastroenterol; 1984 May; 19(3):307-14. PubMed ID: 6740206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The [14C]-triolein breath test is not valid as a test of fat absorption.
    Pedersen NT; Jørgensen BB; Rannem T
    Scand J Clin Lab Invest; 1991 Dec; 51(8):699-703. PubMed ID: 1806985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
    Lindblad A; Glaumann H; Strandvik B
    Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.
    Stiehl A; Raedsch R; Rudolph G
    Gastroenterology; 1990 Feb; 98(2):424-8. PubMed ID: 2295398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
    Kutz K; Schulte A
    Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A syndrome of cirrhosis, achlorhydria, small intestinal bacterial overgrowth, and fat malabsorption.
    Shindo K; Machida M; Miyakawa K; Fukumura M
    Am J Gastroenterol; 1993 Dec; 88(12):2084-91. PubMed ID: 8249977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.